MXPA03001607A - Nuevos macrolidos con actividad antibacteriana. - Google Patents
Nuevos macrolidos con actividad antibacteriana.Info
- Publication number
- MXPA03001607A MXPA03001607A MXPA03001607A MXPA03001607A MXPA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A MX PA03001607 A MXPA03001607 A MX PA03001607A
- Authority
- MX
- Mexico
- Prior art keywords
- antibacterial activity
- new macrolides
- heterocyclyl
- hydrogen
- formula
- Prior art date
Links
- 239000003120 macrolide antibiotic agent Substances 0.000 title abstract 2
- 229940041033 macrolides Drugs 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117971 | 2000-08-22 | ||
| PCT/EP2001/009560 WO2002016380A1 (en) | 2000-08-22 | 2001-08-20 | New macrolides with antibacterial activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001607A true MXPA03001607A (es) | 2003-06-04 |
Family
ID=8169600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001607A MXPA03001607A (es) | 2000-08-22 | 2001-08-20 | Nuevos macrolidos con actividad antibacteriana. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6740642B2 (enExample) |
| EP (1) | EP1313751B1 (enExample) |
| JP (1) | JP4162992B2 (enExample) |
| KR (1) | KR100502031B1 (enExample) |
| CN (1) | CN1234718C (enExample) |
| AT (1) | ATE408614T1 (enExample) |
| AU (1) | AU2001282105A1 (enExample) |
| BR (1) | BR0113472A (enExample) |
| CA (1) | CA2419296C (enExample) |
| DE (1) | DE60135859D1 (enExample) |
| ES (1) | ES2313975T3 (enExample) |
| MX (1) | MXPA03001607A (enExample) |
| WO (1) | WO2002016380A1 (enExample) |
| ZA (1) | ZA200301047B (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ20031751A3 (cs) * | 2000-12-21 | 2004-03-17 | Glaxo Group Limited | Makrolidy |
| FR2826274B1 (fr) * | 2001-06-21 | 2003-09-26 | Aventis Pharma Sa | Formulation pharmaceutique au gout masque et son procede de preparation |
| JP2005503416A (ja) | 2001-09-17 | 2005-02-03 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ６−ｏ−カルバメート−１１，１２−ラクト−ケトライド抗菌剤 |
| US6995143B2 (en) * | 2002-02-28 | 2006-02-07 | Basilea Pharmaceutica Ag | Macrolides with antibacterial activity |
| US6727229B2 (en) * | 2002-08-19 | 2004-04-27 | Enanta Pharmaceuticals, Inc. | 11,12-substituted lactone ketolide derivatives having antibacterial activity |
| US6720308B1 (en) | 2002-11-07 | 2004-04-13 | Enanta Pharmaceuticals, Inc. | Anhydrolide derivatives having antibacterial activity |
| WO2004108745A2 (en) * | 2003-06-05 | 2004-12-16 | Enanta Pharmaceuticals, Inc. | 11-12 bicyclic erythromycin derivatives |
| US6790835B1 (en) | 2003-06-05 | 2004-09-14 | Enanta Pharmaceuticals, Inc. | Bicyclic macrolide derivatives |
| US6774115B1 (en) | 2003-06-05 | 2004-08-10 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic ketolides |
| US6716820B1 (en) | 2003-06-05 | 2004-04-06 | Enanta Pharmaceuticals, Inc. | 6-O-substituted bicyclic macrolides |
| US6765016B1 (en) | 2003-06-05 | 2004-07-20 | Enanta Pharmaceuticals, Inc. | Bicyclic ketolide derivatives |
| US20040254126A1 (en) * | 2003-06-05 | 2004-12-16 | Yao-Ling Qiu | 11-12 Bicyclic erythromycin derivatives |
| WO2006065721A2 (en) * | 2004-12-13 | 2006-06-22 | Enanta Pharmaceuticals, Inc. | 11, 12-lactone bicyclolides |
| CN101115764B (zh) * | 2005-02-09 | 2012-09-26 | 巴斯利尔药物股份公司 | 大环内酯类化合物 |
| JP5112079B2 (ja) * | 2005-02-09 | 2013-01-09 | バジリア ファルマスーチカ アーゲー | 新規なマクロライド |
| US7517859B2 (en) * | 2005-05-04 | 2009-04-14 | Enanta Pharmaceuticals, Inc. | Spirocyclic bicyclolides |
| EP1928893A2 (en) | 2005-08-24 | 2008-06-11 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| KR101239490B1 (ko) * | 2006-08-09 | 2013-03-05 | 바실리어 파마슈티카 아게 | 염증성 및 알러지성 질환에 유용한 새로운 마크로라이드 |
| KR20090042971A (ko) * | 2006-08-24 | 2009-05-04 | 욱크하르트 리서치 센터 | 항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드 |
| EP2245038B1 (en) * | 2008-02-08 | 2018-11-07 | Basilea Pharmaceutica AG | New macrolides and their use |
| PL2247294T3 (pl) | 2008-02-08 | 2014-09-30 | Basilea Pharmaceutica Ag | Makrolidy do leczenia chorób przez hamowanie PDE |
| AU2010252641B2 (en) | 2009-05-27 | 2015-09-17 | Wockhardt Research Centre | Ketolide compounds having antimicrobial activity |
| US8796474B1 (en) | 2010-08-23 | 2014-08-05 | Rutgers, The State University Of New Jersey | Macrolide compounds and methods and intermediates useful for their preparation |
| CN102417530A (zh) * | 2010-09-26 | 2012-04-18 | 中国医学科学院药物研究所 | 广谱抗菌素红霉素a大环酮内酯类衍生物的合成方法和用途 |
| MX348084B (es) | 2010-12-09 | 2017-05-26 | Wockhardt Ltd | Compuestos de cetolido. |
| WO2012117357A2 (en) | 2011-03-01 | 2012-09-07 | Wockhardt Limited | Process for preparation of ketolide intermediates |
| CA2889251A1 (en) * | 2012-12-31 | 2014-07-03 | Basilea Pharmaceutica Ag | Selected macrolides with pde4-inhibiting activity |
| EP3402467A1 (en) | 2016-01-12 | 2018-11-21 | Wockhardt Limited | Pharmaceutical compositions |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
2001
- 2001-08-20 MX MXPA03001607A patent/MXPA03001607A/es active IP Right Grant
- 2001-08-20 CN CNB018160891A patent/CN1234718C/zh not_active Expired - Fee Related
- 2001-08-20 KR KR10-2003-7002616A patent/KR100502031B1/ko not_active Expired - Fee Related
- 2001-08-20 WO PCT/EP2001/009560 patent/WO2002016380A1/en not_active Ceased
- 2001-08-20 AU AU2001282105A patent/AU2001282105A1/en not_active Abandoned
- 2001-08-20 BR BR0113472-8A patent/BR0113472A/pt not_active Application Discontinuation
- 2001-08-20 ES ES01960680T patent/ES2313975T3/es not_active Expired - Lifetime
- 2001-08-20 DE DE60135859T patent/DE60135859D1/de not_active Expired - Lifetime
- 2001-08-20 AT AT01960680T patent/ATE408614T1/de not_active IP Right Cessation
- 2001-08-20 EP EP01960680A patent/EP1313751B1/en not_active Expired - Lifetime
- 2001-08-20 US US10/362,526 patent/US6740642B2/en not_active Expired - Lifetime
- 2001-08-20 CA CA002419296A patent/CA2419296C/en not_active Expired - Fee Related
- 2001-08-20 JP JP2002521477A patent/JP4162992B2/ja not_active Expired - Fee Related
-
2003
- 2003-02-06 ZA ZA200301047A patent/ZA200301047B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1313751B1 (en) | 2008-09-17 |
| EP1313751A1 (en) | 2003-05-28 |
| CN1464880A (zh) | 2003-12-31 |
| CA2419296A1 (en) | 2002-02-28 |
| CN1234718C (zh) | 2006-01-04 |
| JP4162992B2 (ja) | 2008-10-08 |
| ES2313975T3 (es) | 2009-03-16 |
| DE60135859D1 (de) | 2008-10-30 |
| ZA200301047B (en) | 2004-05-06 |
| KR20030029839A (ko) | 2003-04-16 |
| US6740642B2 (en) | 2004-05-25 |
| ATE408614T1 (de) | 2008-10-15 |
| US20030199459A1 (en) | 2003-10-23 |
| WO2002016380A1 (en) | 2002-02-28 |
| JP2004506740A (ja) | 2004-03-04 |
| KR100502031B1 (ko) | 2005-07-25 |
| CA2419296C (en) | 2008-12-09 |
| BR0113472A (pt) | 2003-07-01 |
| AU2001282105A1 (en) | 2002-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03001607A (es) | Nuevos macrolidos con actividad antibacteriana. | |
| HK1046688A1 (zh) | 喹唑啉化合物和含有喹唑啉化合物的藥物組合物 | |
| FR2742757B1 (fr) | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments | |
| DK0975595T3 (da) | Kokainanaloger | |
| ATE446758T1 (de) | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts | |
| ATE541576T2 (de) | 2'-o,4'-c-methylen bicyclonukleoside | |
| CA2469813A1 (en) | Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 | |
| CA2476884A1 (en) | Macrolides with antibacterial activity | |
| YU50002A (sh) | Supstituisani piperidini, lekovi koji sadrže ova jedinjenja i postupci za njihovu proizvodnju | |
| AU2001232287A1 (en) | Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both | |
| NO991700L (no) | Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer | |
| IL145005A0 (en) | 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS | |
| MXPA03001377A (es) | Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion. | |
| EP1153924A3 (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
| MY123310A (en) | Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions | |
| DE69907419D1 (en) | Antitumorwirkstoffe | |
| WO2004108664A3 (de) | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung | |
| MXPA03011682A (es) | Derivados sustituidos de n-acil -anilina, su preparacion y su uso como medicamento. | |
| WO1999004770A3 (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| BR0104358A (pt) | Formulações de taxana tendo solubilidade aperfeiçoada | |
| HRP930014B1 (enExample) | ||
| WO2006034822A8 (de) | Neue substituierte thiophencarbonsäureamide, deren herstellung und deren verwendung als arzneimittel | |
| FR2804958B1 (fr) | Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant | |
| EP0497978A4 (en) | Cephalosporin compounds and production thereof | |
| FR2760017B1 (fr) | Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |